GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Oyj (LTS:0M2O) » Definitions » Debt-to-Revenue

Orion Oyj (LTS:0M2O) Debt-to-Revenue : 0.14 (As of Sep. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Orion Oyj Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Orion Oyj's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was €29 Mil. Orion Oyj's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was €228 Mil. Orion Oyj's annualized Revenue for the quarter that ended in Sep. 2024 was €1,885 Mil. Orion Oyj's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 was 0.14.


Orion Oyj Debt-to-Revenue Historical Data

The historical data trend for Orion Oyj's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Oyj Debt-to-Revenue Chart

Orion Oyj Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.10 0.10 0.16 0.17

Orion Oyj Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.17 0.16 0.16 0.20 0.14

Competitive Comparison of Orion Oyj's Debt-to-Revenue

For the Drug Manufacturers - General subindustry, Orion Oyj's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orion Oyj's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orion Oyj's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Orion Oyj's Debt-to-Revenue falls into.



Orion Oyj Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Orion Oyj's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(29.1 + 171) / 1189.6
=0.17

Orion Oyj's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(29.3 + 227.5) / 1885.2
=0.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2024) Revenue data.


Orion Oyj Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Orion Oyj's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Orion Oyj Business Description

Address
Orionintie 1, Espoo, FIN, FI-02200
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. Orion mainly serves Finland but also has a presence in other European countries, North America and other countries.

Orion Oyj Headlines

No Headlines